(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ: ARCT) slid 5.06% to $25.31 at 16:24 EST on Thursday, after three consecutive sessions in a row of losses. NASDAQ is falling 1.3% to $14,154.02, after two consecutive sessions in a row of losses. This seems, as yet, an all-around bearish trend trading session today.

Arcturus Therapeutics’s last close was $26.66, 78.5% below its 52-week high of $124.00.


Today’s last reported volume for Arcturus Therapeutics is 562696 which is 7.03% below its average volume of 605288.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the current quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.


Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 5.94%, a negative 1.69%, and a positive 4.25%, respectively.

Arcturus Therapeutics’s highest amplitude of average volatility was 10.79% (last week), 4.69% (last month), and 4.25% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $25.31 at 16:24 EST, way under its 52-week high of $124.00 and higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way under its 50-day moving average of $40.67 and way below its 200-day moving average of $40.29.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here